Coronaphobia in Rheumatic Diseases

NCT05554029 | Unknown

• 1 other identifier: 15-23
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

COVID-19 is a contagious respiratory disease that is caused Severe Acute Respiratory Syndrome causing Coronavirus-2 (SARS-CoV-2). The most common symptoms are fever, cough and dyspnoea. Patients with rheumatic diseases are at higher risk of infections because of disease activity and immunosuppression. In addition, old age and having concomitant chronic disease are among risk factors for coronavirus. Therefore, national health services recommend patients to practice self-isolation and self-quarantine.

Conditions

Rheumatic Diseases

Keywords

coronaphobia; Rheumatic diseases; COVID-19

Outcome Measures

Primary Outcomes (1)

• Covid-19 Phobia Scale

  Covid-19 Phobia Scale (C19P-S) was developed by Arpaci et al. C19P-S is a self-reported questionnaire consisting of 20 items and four, i.e., psychological, psychosomatic, economic, and social, subscales. All items are rated on a 5-point scale from "strongly disagree" to "strongly agree". The total score ranges from 20 to 100 points;,the higher the score, the higher is the level of coronaphobia.

  2 minutes

Secondary Outcomes (1)

• Hospital Anxiety and Depression Scale

  3 minutes

Study Arms (1)

Study group

EXPERIMENTAL

Patients with rheumatic diseases

Diagnostic Test: Coronaphobia

Interventions

Coronaphobia DIAGNOSTIC_TEST

Coronophobia will be assessed with COVID-19-phobia scale.

Study group

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Between the ages of 18 to 65
• Have diagnosed with Romatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erthematosus or Fibromyalgia

You may not qualify if:

• Being pregnant
• Diagnosed with malignancy
• Had changes of medical treatment in the last 3 months
• Had dysfunction that limited physical activity such as severe neurological impairment, immobility or cooperation deficits

Sponsors & Collaborators

• Gazi University: lead
• Firat University: collaborator

Study Sites (1)

Songul Baglan Yentur

Ankara, 06560, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Rheumatic Diseases; COVID-19

Condition Hierarchy (Ancestors)

Musculoskeletal Diseases; Connective Tissue Diseases; Skin and Connective Tissue Diseases; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Songul B Yentur

  Gazi University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Songul B Yentur

CONTACT

+90 424 2370000; songulbaglan23@hotmail.com

Songul B Yentur

CONTACT

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant professor

Study Record Dates

• First Submitted: September 21, 2022
• First Posted: September 26, 2022
• Study Start: September 25, 2022
• Primary Completion: November 20, 2022
• Study Completion: December 20, 2022
• Last Updated: September 26, 2022

Record last verified: 2022-09

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)